People
The people behind the science.
Leadership
Board and management.
Dr M. Ganesan
Founder & Managing Director
PhD, Applied Sciences, College of Engineering, Anna University
A first-generation entrepreneur, he established his research and development centre in 2005 and has set up R&D facilities for clinical research, formulation and API development across pharma and biotech.
- R&D facility set-up
- Formulation
- API development
- Clinical research
Ms Vasanthi
Director, Project Management
MBA
Ms Vasanthi heads project management at KMS and is accountable for every partner programme from agreement to delivery. She brings the formulation, analytical, technology-transfer and regulatory teams onto one plan, and holds each programme to its agreed scope, budget and timeline. Her remit covers formulation development, technology transfer and dossier development for regulatory authorities including the US FDA, and she is the first point of contact for new business enquiries.
- Programme management
- Formulation development
- Technology transfer
- Dossier development
- Partner relations
Scientific team
Scientific leads.
Dr S. John Prasanna
Senior Analytical Consultant
PhD, Analytical Chemistry, JNTU Hyderabad · MSc, Applied Chemistry, Anna University · BSc, Chemistry, Madras Christian College
Dr Prasanna brings 25 years in pharmaceutical analytical development across APIs, injectables, CRO operations and regulatory compliance, with senior roles at Orchid Pharma, Syngene International, Strides Shasun Research Centre, Aurobindo Pharma Research Centre and IIT Kanpur. His work spans method development, validation and transfer, stability studies, impurity characterisation and instrument qualification on HPLC, LC-MS, GC-MS, NMR, HRMS, PXRD, DSC and FTIR, with particular depth in impurity profiling, nitrosamine risk assessment and polymorphism. He has supported DMF and ANDA submissions to ICH, US FDA and EMA requirements, has published widely and holds an Indian patent.
- Method development & validation
- Impurity profiling
- Nitrosamine & GTI risk assessment
- DMF / ANDA support
- Polymorphism & solid state
- Stability studies
- IQ/OQ/PQ
- GLP & data integrity
More than 100 scientists work across formulation, analytical development and technology transfer.V-05 Further board members and scientific profiles to be added.V-22
Start a conversation
Where does your programme stand?
Tell us the molecule, the dosage form and the market you are filing in. A programme lead will read it and reply with what we would do next.
Business enquiries: vasanthi@kmshc.com · +91 97898 75194V-23